IMPACT THERAP-B Concludes Stabilization Period with Full Exercise of Over-Allotment Option

Stock News
Jun 08

The stabilization period relating to the company's global offering concluded on Sunday, June 7, 2026, which is the 30th day after the deadline for submitting Hong Kong public offering applications.

The stabilising actions undertaken by the stabilisation manager, Goldman Sachs (Asia) L.L.C., or any of its affiliates or persons acting on its behalf, during the stabilisation period are as follows: (1) an over-allocation of a total of 6,296,400 H Shares in the International Offering, representing approximately 15% of the total number of Offer Shares initially available under the Global Offering prior to any exercise of the Over-allotment Option; and (2) the full exercise of the Over-allotment Option by the Joint Global Coordinators (for themselves and on behalf of the International Underwriters) on Friday, June 5, 2026, at a price of HK$20.10 per H Share (being the offer price per H Share under the Global Offering, excluding 1% brokerage commission, 0.0027% SFC transaction levy, 0.00565% SEHK trading fee and 0.00015% FRC transaction levy), involving a total of 6,296,400 H Shares, to expedite the delivery of a portion of the H Shares to placees who have agreed to defer the delivery of their relevant H Shares subscribed under the Global Offering.

During the stabilisation period, the stabilisation manager did not purchase or sell any H Shares in the market for stabilisation purposes.

Following the full exercise of the Over-allotment Option and the end of the stabilisation period, the Company will continue to comply with the public float requirements under Rule 19A.28B(1) of the Listing Rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10